The role of metformin in the treatment of type 2 diabetes and obesity's
Topic: Mutual association and connection study between the obesity, visceral obesity, insulin desensitation (with the conesquential hyperinsulinemia), type 2 diabetes, dyslipoproteinemia and anthropometric characteristics of the patients with the metabolic syndrom are the subject of many epidemiolog...
Main Author: | Vuković Mira H. |
---|---|
Format: | Article |
Language: | English |
Published: |
Srpsko lekarsko drustvo
2016-01-01
|
Series: | Hospital Pharmacology |
Subjects: | |
Online Access: | http://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2016/2334-94921602409V.pdf |
Similar Items
-
Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01) -
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
by: Zhang Q, et al.
Published: (2020-12-01) -
The Effects of Combined Insulin and Metformin Therapy in Obese Patients with Diabetes Mellitus Type 2 in the Early Stage of the Disease
by: Emela Mujić-Skikić, et al.
Published: (2008-08-01) -
Association between metformin treatment and coronary artery inflammation based on pericoronary adipose tissue attenuation in type 2 diabetes mellitus patients
by: Yuankang Liu, et al.
Published: (2024-04-01) -
The effect of metformin on fasting and postprandial insulin secretion in obese patients with diabetes mellitus type 2
by: Vuković Mira, et al.
Published: (2007-01-01)